| Product Name | MF | CAS | Details |
|---|
| N,N'-Desethylene-N,N'-diforMyl Levofloxacin | C18H18FN3O6 | 151377-74-1 | Details |
| Trelagliptin IMpurity | C8H4Br2FN | 77532-85-5 | Details |
| Iptazosole impurity | Details |
| Cefixime Impurity | C17H16N2O4S | 33748-00-4 | Details |
| Linagliptin iMpurity | C25H28N8O2 | 2140263-92-7 | Details |
| LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) | C8H14N2O3 | 1933471-30-7 | Details |
| Canagliflozin iMpurity | Details |
| Cefaclor EP IMpurity | Details |
| LCZ Impurity | C20H25NO2 | 753421-85-1 | Details |
| EveroliMus iMpurity | 1661009-29-5 | Details |
| 6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE | C14H16Br2N2O | 21237-84-3 | Details |
| Methanesulfonate methanesulfonamide impurity | C2H8NO5S2- | Details |
| Cinacalcet IMpurity | C22H26F3N | 1229224-93-4 | Details |
| Crizotinib iMpurity | Details |
| Afatinib impurity | Details |
| 6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone | C12H13N3O3 | 1405180-57-5 | Details |
| Lurasidon hydrochloride iMpurity | C19H28N4S | 1260138-03-1 | Details |
| Cefoxitin Impurity | Details |
| Lenalidomide impurity (spot) | Details |
| AMlodipine iMpurity | C26H31ClN2O8S | Details |
| Pabuxilibu impurities | Details |
| Dipyridamole Impurity Reference | Details |
| RaMelteon iMpurity | C16H20BrNO2 | 1204581-51-0 | Details |
| Edoxaban iMpurities | C14H27N3O3 | 1255529-34-0 | Details |
| Pabuximab impurity | Details |
| Genetically modified soybean standard | Details |
| BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride | C14H21BrN2 | 132004-28-5 | Details |
| Paroxetine IMpurity | Details |
| IMatinib iMpurity | C24H21N5O | 152459-96-6 | Details |
| Erythromycin Impurity | C37H65NO12 | 40554-78-7 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||